Mycobacterium tuberculosis: ecology and evolution of a human bacterium.

Some species of the Mycobacterium tuberculosis complex (MTBC), particularly Mycobacterium tuberculosis, which causes human tuberculosis (TB), are the first cause of death linked to a single pathogen worldwide. In the last decades, evolutionary studies have much improved our knowledge on MTBC history and have highlighted its long co-evolution with humans. Its ability to remain latent in humans, the extraordinary proportion of asymptomatic carriers (one-third of the entire human population), the deadly epidemics and the observed increasing level of resistance to antibiotics are proof of its evolutionary success. Many MTBC molecular signatures show not only that these bacteria are a model of adaptation to humans but also that they have influenced human evolution. Owing to the unbalance between the number of asymptomatic carriers and the number of patients with active TB, some authors suggest that infection by MTBC could have a protective role against active TB disease and also against other pathologies. However, it would be inappropriate to consider these infectious pathogens as commensals or symbionts, given the level of morbidity and mortality caused by TB.

[1]  Kelly M. Harkins,et al.  Pre-Columbian mycobacterial genomes reveal seals as a source of New World human tuberculosis , 2014, Nature.

[2]  Y. Madec,et al.  Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  S. Kuo,et al.  The Pattern of Cytokine Production In Vitro Induced by Ancient and Modern Beijing Mycobacterium tuberculosis Strains , 2014, PloS one.

[4]  M. Drancourt,et al.  Long-term survival of tuberculosis complex mycobacteria in soil. , 2014, Microbiology.

[5]  F. Thomas,et al.  Of parasites and men. , 2013, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[6]  Y. Madec,et al.  Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial , 2013, AIDS.

[7]  K. Holt,et al.  Out-of-Africa migration and Neolithic co-expansion of Mycobacterium tuberculosis with modern humans , 2013, Nature Genetics.

[8]  S. Niemann,et al.  Clade-Specific Virulence Patterns of Mycobacterium tuberculosis Complex Strains in Human Primary Macrophages and Aerogenically Infected Mice , 2013, mBio.

[9]  K. Sainis,et al.  Drug Resistant Clinical Isolates of Mycobacterium tuberculosis from Different Genotypes Exhibit Differential Host Responses in THP-1 Cells , 2013, PloS one.

[10]  S. Kaufmann.  Tuberculosis vaccines: time to think about the next generation. , 2013, Seminars in immunology.

[11]  S. Gordon,et al.  Mycobacterial Lineages Causing Pulmonary and Extrapulmonary Tuberculosis, Ethiopia , 2013, Emerging infectious diseases.

[12]  E. Willery,et al.  Genome analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of the etiologic agent of tuberculosis , 2013, Nature Genetics.

[13]  Thai Son Nguyen,et al.  High Prevalence of Beijing and EAI4-VNM Genotypes among M. tuberculosis Isolates in Northern Vietnam: Sampling Effect, Rural and Urban Disparities , 2012, PloS one.

[14]  S. Kaufmann.  Tuberculosis vaccine development: strength lies in tenacity. , 2012, Trends in immunology.

[15]  Nalin Rastogi,et al.  SITVITWEB--a publicly available international multimarker database for studying Mycobacterium tuberculosis genetic diversity and molecular epidemiology. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[16]  D. Scott‐Algara,et al.  Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis. , 2012, Blood.

[17]  S. Gagneux.  Host–pathogen coevolution in human tuberculosis , 2012, Philosophical Transactions of the Royal Society B: Biological Sciences.

[18]  S. Kaufmann.  Fact and fiction in tuberculosis vaccine research: 10 years later. , 2011, The Lancet. Infectious diseases.

[19]  M. Daffé,et al.  Clinical characteristics of the smooth tubercle bacilli 'Mycobacterium canettii' infection suggest the existence of an environmental reservoir. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  Nalin Rastogi,et al.  The Guinea-Bissau Family of Mycobacterium tuberculosis Complex Revisited , 2011, PloS one.

[21]  C. K. Kwan,et al.  HIV and Tuberculosis: a Deadly Human Syndemic , 2011, Clinical Microbiology Reviews.

[22]  I. Comas,et al.  Human Macrophage Responses to Clinical Isolates from the Mycobacterium tuberculosis Complex Discriminate between Ancient and Modern Lineages , 2011, PLoS pathogens.

[23]  D. Russell.  Mycobacterium tuberculosis and the intimate discourse of a chronic infection , 2011, Immunological reviews.

[24]  Gilles Vergnaud,et al.  Molecular characteristics of "Mycobacterium canettii" the smooth Mycobacterium tuberculosis bacilli. , 2010, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[25]  B. D. de Jong,et al.  Mycobacterium africanum—Review of an Important Cause of Human Tuberculosis in West Africa , 2010, PLoS neglected tropical diseases.

[26]  J. Galagan,et al.  Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved , 2010, Nature Genetics.

[27]  S. Borrell,et al.  Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. , 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[28]  M. Netea,et al.  Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis. , 2009, The Journal of infectious diseases.

[29]  S. Niemann,et al.  Autophagy Gene Variant IRGM −261T Contributes to Protection from Tuberculosis Caused by Mycobacterium tuberculosis but Not by M. africanum Strains , 2009, PLoS pathogens.

[30]  C. Roberts,et al.  Letter to the editor: was tuberculosis present in Homo erectus in Turkey? , 2009, American journal of physical anthropology.

[31]  Scott M. Williams,et al.  The Genetic Structure and History of Africans and African Americans , 2009, Science.

[32]  Stefan Niemann,et al.  High Functional Diversity in Mycobacterium tuberculosis Driven by Genetic Drift and Human Demography , 2008, PLoS biology.

[33]  R. Wilkinson,et al.  The clinical consequences of strain diversity in Mycobacterium tuberculosis. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[34]  P. Small,et al.  Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. , 2008, The Journal of infectious diseases.

[35]  Falk Hildebrand,et al.  Origin, Spread and Demography of the Mycobacterium tuberculosis Complex , 2008, PLoS pathogens.

[36]  J. Farrar,et al.  The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis , 2008, PLoS pathogens.

[37]  O. Werz,et al.  ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. , 2007, Human molecular genetics.

[38]  M. Blaser,et al.  The equilibria that allow bacterial persistence in human hosts , 2007, Nature.

[39]  Sebastien Gagneux,et al.  Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. , 2007, The Lancet. Infectious diseases.

[40]  F. Chevenet,et al.  First Molecular Epidemiology Study of Mycobacterium tuberculosis in Burkina Faso , 2007, Journal of Clinical Microbiology.

[41]  P. Van de Perre,et al.  Genetic diversity and population structure of Mycobacterium tuberculosis in HIV-1-infected compared with uninfected individuals in Burkina Faso , 2007, AIDS.

[42]  S. Kaufmann,et al.  Exploiting immunology and molecular genetics for rational vaccine design against tuberculosis. , 2006, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[43]  N. Smith.  A Re-Evaluation of M. prototuberculosis , 2006, PLoS pathogens.

[44]  S. Godreuil,et al.  Pulmonary Tuberculosis and Mycobacterium Tuberculosis: Modern Molecular Epidemiology and Perspectives , 2006 .

[45]  P. V. van Helden,et al.  Drug resistance in Mycobacterium tuberculosis. , 2006, Current issues in molecular biology.

[46]  Leen Rigouts,et al.  Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology , 2006, BMC Microbiology.

[47]  Stefan Niemann,et al.  Variable host-pathogen compatibility in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Brosch,et al.  Ancient Origin and Gene Mosaicism of the Progenitor of Mycobacterium tuberculosis , 2005, PLoS pathogens.

[49]  Alimuddin Zumla,et al.  Immune responses to tuberculosis in developing countries: implications for new vaccines , 2005, Nature Reviews Immunology.

[50]  M. Reed,et al.  Virulence of selected Mycobacterium tuberculosis clinical isolates in the rabbit model of meningitis is dependent on phenolic glycolipid produced by the bacilli. , 2005, The Journal of infectious diseases.

[51]  T. Hampton.  TB drug research picks up the pace. , 2005, JAMA.

[52]  M. Reed,et al.  A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response , 2004, Nature.

[53]  Galit Lev-Maor,et al.  Tuberculosis: from prehistory to Robert Koch, as revealed by ancient DNA. , 2004, The Lancet. Infectious diseases.

[54]  V. Baumanis,et al.  Prevalence of Beijing genotype in Latvian multidrug-resistant Mycobacterium tuberculosis isolates. , 2003, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[55]  Julian Parkhill,et al.  The complete genome sequence of Mycobacterium bovis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[56]  V. Vincent,et al.  Two Cases of Pulmonary Tuberculosis Caused by Mycobacterium tuberculosis subsp. canetti , 2002, Emerging infectious diseases.

[57]  Y. Balabanova,et al.  Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family , 2002, Emerging infectious diseases.

[58]  M. Lipsitch,et al.  Historical intensity of natural selection for resistance to tuberculosis. , 2002, Genetics.

[59]  M. Filipenko,et al.  Nosocomial Outbreak of Multidrug-Resistant Tuberculosis Caused by a Strain of Mycobacterium tuberculosis W-Beijing Family in St. Petersburg, Russia , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[60]  C. Buchrieser,et al.  A new evolutionary scenario for the Mycobacterium tuberculosis complex , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  G. Kaplan,et al.  Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. van Soolingen,et al.  Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. , 2000, Emerging infectious diseases.

[63]  K. Hasløv,et al.  Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[64]  R. Reves,et al.  Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[66]  J. Caylà,et al.  Characteristics of tuberculosis patients who generate secondary cases. , 1997, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[67]  B. R. Levin,et al.  The evolution and maintenance of virulence in microparasites. , 1996, Emerging infectious diseases.

[68]  A. Dannenberg.  Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. , 1991, Immunology today.

[69]  P. Saliou,et al.  [Tuberculosis infection in a cattle-breeding region in Sahelian Africa]. , 1986, Annales de la Societe belge de medecine tropicale.

[70]  W. Stead,et al.  What's new in tuberculosis? , 1981, The American journal of medicine.

[71]  J. Krebs,et al.  Arms races between and within species , 1979, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[72]  Comstock Gw.  Tuberculosis in twins: a re-analysis of the Prophit survey. , 1978, The American review of respiratory disease.

[73]  D. Mitchison,et al.  A comparison of the virulence in guinea-pigs of South Indian and British tubercle bacilli. , 1960, Tubercle.

[74]  E. Willery,et al.  Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis , 2020 .

[75]  S. Gagneux.  Genetic diversity in Mycobacterium tuberculosis. , 2013, Current topics in microbiology and immunology.

[76]  J. Casanova,et al.  Genetic dissection of immunity to mycobacteria: the human model. , 2002, Annual review of immunology.

[77]  Steven A. Frank,et al.  Immunology and Evolution of Infectious Disease , 2002 .

[78]  A. Ginsberg.  What's new in tuberculosis vaccines? , 2002, Bulletin of the World Health Organization.

[79]  G. Comstock.  Tuberculosis in twins: a re-analysis of the Prophit survey. , 1978, The American review of respiratory disease.

[80]  M. Lefèvre,et al.  [Mycobacteria of animal origin isolated by the Muraz Center from 1965 to 1968: technics of isolation and identification; results]. , 1969, Revue d'elevage et de medecine veterinaire des pays tropicaux.